Monday, December 30, 2024 8:30:16 AM
vrax...........................https://stockcharts.com/h-sc/ui?s=vrax&p=W&b=5&g=0&id=p86431144783
Recent VRAX News
- Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation • PR Newswire (US) • 03/31/2026 11:34:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:05:23 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2026 09:01:50 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/31/2025 09:59:31 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 12/18/2025 09:06:17 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/04/2025 09:07:11 PM
- Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement • PR Newswire (US) • 12/04/2025 09:05:00 PM
- Virax Biolabs Group Limited Announces $5 Million Private Placement • PR Newswire (US) • 12/03/2025 06:53:00 PM
- Virax Biolabs soars as company advances diagnostics for post-infection syndromes • IH Market News • 12/03/2025 02:45:18 PM
- Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders • PR Newswire (US) • 12/03/2025 12:34:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/02/2025 09:42:09 PM
- Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes • PR Newswire (US) • 11/03/2025 01:29:00 PM
- Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September • PR Newswire (US) • 08/26/2025 11:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/30/2025 08:12:57 PM
- Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy • PR Newswire (US) • 07/29/2025 11:35:00 AM
- Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency • PR Newswire (US) • 07/18/2025 08:15:00 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/02/2025 09:29:28 PM
